en

PRODUCT DETAIL

Nepexto 25 mg injekčný roztok v naplnenej injekčnej striekačke

Code 4874D
MA number EU/1/20/1436/001
Product Form: sol inj 4x0,5 ml/25 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Biosimilar Collaborations Ireland Limited, Ireland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB01 Etanercept
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 20.05.2020
Validity: 20.05.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 08.09.2023
eu-flag.png sk-flag.png